Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
First-in-Class Mitogen-Activated Protein Kinase p38α: MAPK-Activated Protein Kinase-2 (MK2) Dual Signal Modulator with Anti-inflammatory and Endothelial-stabilizing Properties.
J Pharmacol Exp Ther. 2024 Sep 16:JPET-AR-2024-002281. doi: 10.1124/jpet.124.002281. Online ahead of print.
J Pharmacol Exp Ther. 2024.
PMID: 39284624
Free article.
Progress in the development of kinase inhibitors for treating asthma and COPD.
McClean N, Hasday JD, Shapiro P.
McClean N, et al.
Adv Pharmacol. 2023;98:145-178. doi: 10.1016/bs.apha.2023.04.004. Epub 2023 May 3.
Adv Pharmacol. 2023.
PMID: 37524486
Review.
Item in Clipboard
Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer.
Krug LM, Miller VA, Kalemkerian GP, Kraut MJ, Ng KK, Heelan RT, Pizzo BA, Perez W, McClean N, Kris MG.
Krug LM, et al. Among authors: mcclean n.
Ann Oncol. 2000 Feb;11(2):227-8. doi: 10.1023/a:1008349209956.
Ann Oncol. 2000.
PMID: 10761761
Free article.
Clinical Trial.
No abstract available.
Item in Clipboard
Cite
Cite